Response to endobronchial valve treatment: it's all about the target lobe.

Jorine E Hartman Sharyn A Roodenburg Marlies van Dijk T David KosterKarin KloosterDirk-Jan Slebos

Published in: ERJ open research (2023)

We found that target lobe characteristics are the discriminators between responders and nonresponders, which underlines the importance of visual and quantitative assessment of the potential treatment target lobe when selecting patients for EBV treatment.

Keyphrases

end stage renal disease
chronic kidney disease
combination therapy
prognostic factors
risk assessment
epstein barr virus
atrial fibrillation
replacement therapy
peritoneal dialysis